A single-cell atlas of the peripheral immune response in patients with severe COVID-19
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.04.17.20069930: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Subjects and specimen collection: We collected blood from 7 patients enrolled in the Stanford University ICU Biobank study from March-April 2020 after written informed consent from patients or their surrogates (Stanford IRB approval #28205). Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Next, reads were aligned with STAR using the GRCh37 (hg19) human reference genome that included the complete genome sequences for all SARS-CoV-2 strains sequenced from California before March 24, 2020 (10 SARS-CoV-2 sequences). STARsuggested: …SciScore for 10.1101/2020.04.17.20069930: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Subjects and specimen collection: We collected blood from 7 patients enrolled in the Stanford University ICU Biobank study from March-April 2020 after written informed consent from patients or their surrogates (Stanford IRB approval #28205). Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Next, reads were aligned with STAR using the GRCh37 (hg19) human reference genome that included the complete genome sequences for all SARS-CoV-2 strains sequenced from California before March 24, 2020 (10 SARS-CoV-2 sequences). STARsuggested: (STAR, RRID:SCR_015899)Gene pathway and upstream regulator analysis was performed with Ingenuity Pathway Analysis (IPA; Qiagen). Ingenuity Pathway Analysissuggested: (Ingenuity Pathway Analysis, RRID:SCR_008653)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-